Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 646 AL 660

High intensity aerobic exercise improves information processing and motor performance in individuals with Parkinson's disease

Rosenfeldt AB, Koop MM, Fernandez HH, Alberts JL.

Exp Brain Res. 2021 Mar;239(3):777-786. doi: 10.1007/s00221-020-06009-0. Epub 2021 Jan 4.

Extrinsic and Behavioral Fall Risk Factors in People With Parkinson's Disease: An Integrative Review

Kuljeerung O, Lach HW.

Rehabil Nurs. 2021 Jan-Feb 01;46(1):3-10. doi: 10.1097/rnj.0000000000000265.

Extrinsic and Behavioral Fall Risk Factors in People With Parkinson's Disease: An Integrative Review

Rehabil Nurs. 2021 Jan-Feb 01;46(1):E1. doi: 10.1097/RNJ.0000000000000307.

Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?

McAlpine LS, Fesharaki-Zadeh A, Spudich S.

Curr Opin Psychiatry. 2021 Mar 1;34(2):177-185. doi: 10.1097/YCO.0000000000000688.

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

Zecca L, Pifl C, Fahn S, Sulzer D, Fariello RG.

NPJ Parkinsons Dis. 2021 Jan 4;7(1):1. doi: 10.1038/s41531-020-00149-4.

Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease

Suzuki K, Fujita H, Matsubara T, Haruyama Y, Kadowaki T, Funakoshi K, Watanabe Y, Hirata K.

Brain Behav. 2021 Mar;11(3):e02026. doi: 10.1002/brb3.2026. Epub 2021 Jan 5.

Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP.

Neurochem Res. 2021 Mar;46(3):425-438. doi: 10.1007/s11064-020-03187-9. Epub 2021 Jan 5.

Formaldehyde and Brain Disorders: A Meta-Analysis and Bioinformatics Approach

Rana I, Rieswijk L, Steinmaus C, Zhang L.

Neurotox Res. 2021 Jun;39(3):924-948. doi: 10.1007/s12640-020-00320-y. Epub 2021 Jan 5.

Central nervous system delivery of molecules across the blood-brain barrier

Gosselet F, Loiola RA, Roig A, Rosell A, Culot M.

Neurochem Int. 2021 Mar;144:104952. doi: 10.1016/j.neuint.2020.104952. Epub 2021 Jan 2.

Age-related vulnerability to nigral dopaminergic degeneration in rats via Zn(2+)-permeable GluR2-lacking AMPA receptor activation

Nakajima S, Saeki N, Tamano H, Nishio R, Katahira M, Takeuchi A, Takeda A.

Neurotoxicology. 2021 Mar;83:69-76. doi: 10.1016/j.neuro.2020.12.014. Epub 2021 Jan 2.

The Mechanistic Role of Thymoquinone in Parkinson's Disease: Focus on Neuroprotection in Pre-Clinical Studies

Uddin MN, Hoq MI, Jahan I, Siddiqui SA, Clinton CD, Ibrahim M, Islam MS, Jakaria M.

Curr Mol Pharmacol. 2021;14(6):1083-1092. doi: 10.2174/1874467214666210105140944.

An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a

Ammal Kaidery N, Ahuja M, Sharma SM, Thomas B.

Antioxid Redox Signal. 2021 Sep 1;35(7):580-594. doi: 10.1089/ars.2020.8256. Epub 2021 Feb 15.

How microcompetition with latent viruses can cause α synuclein aggregation, mitochondrial dysfunction, and eventually Parkinson's disease

Polansky H, Lori G.

J Neurovirol. 2021 Feb;27(1):52-57. doi: 10.1007/s13365-020-00929-x. Epub 2021 Jan 6.

Nuclear Ubiquitin-Proteasome Pathways in Proteostasis Maintenance

Franić D, Zubčić K, Boban M.

Biomolecules. 2021 Jan 4;11(1):54. doi: 10.3390/biom11010054.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias